![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 9, 5577-5588, February 29, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


1
2
3
4

5
6
From the
Department of Neurochemistry, Max Planck Institute for Brain Research, 60528 Frankfurt, Germany and the
School of Biological Sciences, University of Southampton, Southampton S016 7PX, United Kingdom
Calmodulin (CaM) binds in a Ca2+-dependent manner to the intracellular C-terminal domains of most group III metabotropic glutamate receptors (mGluRs). Here we combined mutational and biophysical approaches to define the structural basis of CaM binding to mGluR 7A. Ca2+/CaM was found to interact with mGluR 7A primarily via its C-lobe at a 1:1 CaM:C-tail stoichiometry. Pulldown experiments with mutant CaM and mGluR 7A C-tail constructs and high resolution NMR with peptides corresponding to the CaM binding region of mGluR 7A allowed us to define hydrophobic and ionic interactions required for Ca2+/CaM binding and identified a 1-8-14 CaM-binding motif. The Ca2+/CaM·mGluR 7A peptide complex displays a classical wraparound structure that closely resembles that formed by Ca2+/CaM upon binding to smooth muscle myosin light chain kinase. Our data provide insight into how Ca2+/CaM regulates group III mGluR signaling via competition with intracellular proteins for receptor-binding sites.
Received for publication, November 20, 2007
* This work was supported by the Max Planck Society (to H. B.), European Community Grant QLG3-CT-2001-00929 (to H. B. and V. O'C.), Fonds der Chemischen Industrie (to H. B.), and the Wessex Medical Trust (to V. O'C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.
1 Present address: Max Planck Institute of Biophysical Chemistry, 37077 Göttingen, Germany.
2 Present address: INSERM Unité 641, Université delaMéditerranée, Institut Jean Roche, FacultédeMédicine Secteur Nord, Boulevard Pierre Dramard, 13916 Marseille Cedex 20, France.
3 Present address: Dept. of Cellular and Developmental Biology, University of Colorado Health Sciences Center, Denver, CO 80045.
4 Present address: Dept. of Chemistry, University of Bristol, Cantocks Close, BS8 1TS Bristol, UK.
5 To whom correspondence may be addressed: Dept. of Neurochemistry, MPI for Brain Research, Deutschordenstrasse 46, 60528 Frankfurt, Germany. Tel.: 49-69-96769-220; Fax: 49-69-96769-441; E-mail: neurochemie{at}mpih-frankfurt.mpg.de. 6 To whom correspondence may be addressed: School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton S016 7PX, UK. Tel.: 44-2380592484; Fax: 44-2380594459; E-mail: jmwe{at}soton.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |